You are here:

ciprofloxacin 3mg/mL + dexamethasone 1mg/mL ear drops (Cilodex)

Advice

following an abbreviated submission:

ciprofloxacin+dexamethasone (Cilodex®) is accepted for restricted use within NHS Scotland.

Indication under review: for treatment of the following infections in adults and children:
Acute otitis media in patients with tympanostomy tubes (AOMT)
Acute otitis externa

SMC restriction: Treatment of acute otitis media in patients with tympanostomy tubes (AOMT).

Cilodex® provides a licensed alternative to “off-label” use of ciprofloxacin and dexamethasone eye drops in the treatment of AOMT and is available at an equivalent cost.

Drug Details

Drug Name: ciprofloxacin 3mg/mL + dexamethasone 1mg/mL ear drops (Cilodex)
SMC Drug ID: 1256/17
Manufacturer: Novartis Pharmaceuticals UK Ltd
Indication: Indication under review: Treatment of the following infections in adults and children: Acute otitis media in patients with tympanostomy tubes (AOMT), Acute otitis externa
BNF Category:
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 10 July 2017

Back